Exuberant inflammation in nicotinamide adenine dinucleotide phosphate-oxidase-deficient mice after allogeneic marrow transplantation.
We have shown that NO and superoxide (O-*2)contribute to donor T cell-dependent lung dysfunction after bone marrow transplantation (BMT) in mice. We hypothesized that inhibiting superoxide production during inducible NO synthase induction would suppress oxidative/nitrative stress and result in less severe lung injury. Irradiated mice lacking the phagocytic NADPH-oxidase (phox(-/-)), a contributor to superoxide generation, were conditioned with cyclophosphamide and given donor bone marrow in the presence or absence of inflammation-inducing allogeneic spleen T cells. On day 7 after allogeneic BMT, survival, weight loss, and indices of lung injury between phox(-/-) and wild-type mice were not different. However, the majority of macrophages/monocytes from phox(-/-) mice given donor T cells produced fewer oxidants and contained less nitrotyrosine than cells obtained from T cell-recipient wild-type mice. Importantly, suppressed oxidative stress was associated with marked infiltration of the lungs with inflammatory cells and was accompanied by increased bronchoalveolar lavage fluid levels of the chemoattractants monocyte chemoattractant protein-1 and macrophage-inflammatory protein-1alpha and impaired clearance of recombinant mouse macrophage-inflammatory protein-1beta from the circulation. Furthermore, cultured macrophages/monocytes from NADPH-deficient mice produced 3-fold more TNF-alpha compared with equal number of cells from NADPH-sufficient mice. The high NO production was not modified during NADPH-oxidase deficiency. We conclude that phox(-/-) mice exhibit enhanced pulmonary influx of inflammatory cells after BMT. Although NO may contribute to increased production of TNF-alpha in phox(-/-) mice, the data suggest that NADPH-oxidase-derived oxidants have a role in limiting inflammation and preventing lung cellular infiltration after allogeneic transplantation.
Yang
Shuxia
S
Department of Pediatrics, Divisions of Pulmonary and Critical Care and Bone Marrow Transplantation and Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Panoskaltsis-Mortari
Angela
A
Shukla
Mayank
M
Blazar
Bruce R
BR
Haddad
Imad Y
IY
D000818:Animals; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D018932:Chemokine CCL2 / Q000096:biosynthesis; D054407:Chemokine CCL4; D006105:Granulomatous Disease, Chronic / Q000209:etiology; D007249:Inflammation / Q000209:etiology* / Q000517:prevention & control; D008168:Lung / Q000473:pathology; D019402:Macrophage Inflammatory Proteins / Q000096:biosynthesis; D051379:Mice; D008810:Mice, Inbred C57BL; D019255:NADPH Oxidases / Q000172:deficiency / Q000502:physiology*; D009569:Nitric Oxide / Q000096:biosynthesis; D018384:Oxidative Stress; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis; D015431:Weight Loss
D018932:Chemokine CCL2; D054407:Chemokine CCL4; D019402:Macrophage Inflammatory Proteins; D014409:Tumor Necrosis Factor-alpha; D009569:Nitric Oxide; D019255:NADPH Oxidases